$VIR Vir Biotechnology, Inc. Insider Trading Week 13/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vir Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vir Biotechnology, Inc. in week 13/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,987 | 0 | 11,976 | 6 K to 12 K (+99.97 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,616,116 | 15.9 M to 15.6 M (-1.78 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,050,547 | 12.3 M to 12.1 M (-1.78 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 5,989 | 0 to 6 K |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,898,335 | 16.2 M to 15.9 M (-1.74 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,268,328 | 12.5 M to 12.3 M (-1.74 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,016 | 0 | 2,030 | 1 K to 2 K (+100.20 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,160 | 0 | 6,320 | 3.2 K to 6.3 K (+100.00 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,616,116 | 15.9 M to 15.6 M (-1.78 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 12,050,547 | 12.3 M to 12.1 M (-1.78 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 1,014 | 0 | 1,014 | 0 to 1 K |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Buy | J | 0.00 | 3,160 | 0 | 3,160 | 0 to 3.2 K |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 282,219 | 0 | 15,898,335 | 16.2 M to 15.9 M (-1.74 %) |
| Apr 01 2021 | VIR | Vir Biotechnology, ... | ARCH Venture Partners IX, LLC | 10% Owner | Sell | J | 0.00 | 217,781 | 0 | 12,268,328 | 12.5 M to 12.3 M (-1.74 %) |
| Mar 31 2021 | VIR | Vir Biotechnology, ... | HANLY ANN M. | Chief Technology Of ... | Option Exercise | A | 48.38 | 60,000 | 2,902,800 | 60,000 | |
| Mar 31 2021 | VIR | Vir Biotechnology, ... | HANLY ANN M. | Chief Technology Of ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |